id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0160-0001,FDA,FDA-2002-E-0160,Determination of Regulatory Review Period for Purposes of Patent Extension; Axert,Notice,General Notice,2002-07-16T04:00:00Z,2002,7,2002-07-16T04:00:00Z,,2025-09-29T23:58:10Z,02-17782,0,0,0900006480493ffb